Project Grant R01DK147266
- The National Institute for Minority Health and Health Disparities awarded the National Bureau of Economic Research Inc. $2,159,469 on September 3, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a Project Grant investigating the geographic distribution of dialysis facility expansion and its effects on health outcomes among patients with end-stage kidney disease. The research will analyze whether the 70 percent increase in dialysis centers over the...
- The National Institute for Minority Health and Health Disparities awarded Duke University $771,059 on August 5, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and test a tailored mHealth coaching and social resource support intervention designed to improve medication adherence and patient activation among kidney transplant recipients in low-resource communities. The project addresses health disparities in post-transplant outcomes, where...
- The National Heart, Lung, and Blood Institute awarded the University of Washington $188,786 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support a K23 career development award focused on investigating sphingolipids as a cardiovascular disease risk factor in patients with kidney disease. The award funds career development and research training for an assistant professor in nephrology at the University of Washington to transition to an independent...
- The National Institute for Minority Health and Health Disparities awarded the University of Utah $769,998 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to investigate genetic determinants of cardiovascular-kidney-metabolic syndrome in Native Hawaiian and Pacific Islander populations. The award funds expansion of the Utah Pacific Islander Study biorepository to enroll more than 1,800 deeply phenotyped Native Hawaiian and Pacific Islander...
- The National Institute for Minority Health and Health Disparities, part of the Department of Health and Human Services National Institutes of Health, awarded Ochin, Inc. a Project Grant of $1,460,161 on August 15, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307). Ochin will create an integrated dataset by harmonizing data from national, state, and local sources to investigate the longitudinal relationship between housing transitions and health outcomes for...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Washington $192,763 on March 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), a Project Grant supporting basic and clinical biomedical research that improves understanding of disease mechanisms and leads to improved prevention, diagnosis, and treatment. The award funds a prospective nested cohort study investigating mechanisms of kidney...
- The National Institute of Nursing Research awarded the University of Washington $308,138 on May 13, 2026, under the Nursing Research program (CFDA 93.361) to assess the feasibility and effectiveness of a community-based heart failure care model. The research evaluates the Community Heart Failure Program (CHFP), a trauma-informed, nurse-led disease management program operated by a safety-net hospital in the Pacific Northwest that serves heart failure patients with adverse social determinants of...
- The National Institute for Minority Health and Health Disparities awarded The Regents of the University of California, San Francisco $2,306,030 on September 13, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct research on hypertension retention and cardiovascular risk reduction among people with HIV who use safety-net clinics. The recipient will conduct an explanatory sequential study combining quantitative survey data and qualitative contextual...
- Federal Grant Award Summary The University of Washington received a $230,439 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2027. The award funds the development and establishment of content validity for a Kidney Transplant Evaluation Patient Reported Experience Measure (KTE-PREM). This initiative...
- The National Institute for Minority Health and Health Disparities, National Institutes of Health, awarded Sojourn Medtech LLC $349,859 on September 17, 2025, to develop a patient-centered self-cannulation training simulator for African American patients with end-stage renal disease under the Minority Health and Health Disparities Research program (CFDA 93.307). The award funds development of a training tool designed to increase self-cannulation competency and promote home hemodialysis adoption...
The National Institute for Minority Health and Health Disparities awarded the University of Washington $2.938 million on September 3, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307). The award funds the ENRICH (Enhancing Kidney Care in Community Health Centers) project, a mixed-methods research initiative to improve kidney disease management in federally qualified health centers, rural health clinics, and other community-based providers serving high-risk populations. The project leverages OCHIN Inc., the nation's largest network of community health centers, which collectively serve over 8 million patients across 2,400 clinics in 43 states. Research objectives include identifying health center factors and services associated with the highest implementation of guideline-based chronic kidney disease care and the lowest risk of adverse kidney outcomes in non-dialysis-dependent patients, and identifying opportunities to improve care delivery and efficiency among vulnerable populations currently underrepresented in kidney disease research. The project period runs from September 3, 2026, through July 31, 2030. Performance takes place at the University of Washington in Seattle, Washington. The University of Washington's Office of Sponsored Programs serves as the prime recipient and administrative gateway for the award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.9m | 9/3/26 |